ExpreS2ion Biotechnologies – 2025 Interim Report (Q3) Presentation

CEO Bent Frandsen and CFO Keith Alexander will present ExpreS2ion Biotechnologies’ 2025 Interim Report (Q3) at a live virtual event hosted by H.C. Andersen Capital on Thursday, November 13, 2025, at 11:00 CET.

The presentation will cover key financial results, recent corporate developments, and upcoming milestones across ExpreS2ion’s immunotherapy and vaccine pipeline. Following the presentation, participants will have the opportunity to ask questions during a live Q&A session.

The event is free and open to all investors. Registration is now available, and attendees are encouraged to submit questions in advance.

Register and join the event here